vidarabine has been researched along with Leukemia, Plasmacytic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björkholm, M; Osby, E | 1 |
| Crollo, R; D'Oronzio, L; Dambra, P; Dell'Osso, A; Grande, M; Lasaracina, E; Loria, MP; Lucivero, G | 1 |
2 other study(ies) available for vidarabine and Leukemia, Plasmacytic
| Article | Year |
|---|---|
Fludarabine and plasma cell leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Humans; Leukemia, Plasma Cell; Male; Middle Aged; Vidarabine | 1995 |
Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Plasma Cell; Leukemia, Prolymphocytic; Lymphocytes; Male; Phenotype; Vidarabine | 1997 |